TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.
URL: http://www.news-medical.net/news/20121102/TransTech-Pharma-to-complete-TTP054-Phase-2-trial-on-type-2-diabetes.aspx
No comments:
Post a Comment